SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28 | -50.9% | 11,835 | 0.0% | 0.00% | – |
| Q2 2023 | $57 | +3.6% | 11,835 | +21.2% | 0.00% | – |
| Q1 2023 | $55 | -12.7% | 9,768 | -13.1% | 0.00% | -100.0% |
| Q4 2022 | $63 | -99.9% | 11,244 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $72,000 | +89.5% | 11,244 | +1.6% | 0.00% | – |
| Q2 2022 | $38,000 | -53.1% | 11,065 | -2.4% | 0.00% | -100.0% |
| Q1 2022 | $81,000 | -60.3% | 11,332 | -53.9% | 0.00% | 0.0% |
| Q4 2021 | $204,000 | +131.8% | 24,576 | +94.6% | 0.00% | 0.0% |
| Q3 2021 | $88,000 | -71.9% | 12,626 | -3.9% | 0.00% | -66.7% |
| Q2 2021 | $313,000 | +48.3% | 13,143 | +52.5% | 0.00% | -62.5% |
| Q4 2020 | $211,000 | -9.8% | 8,621 | +4.4% | 0.01% | -20.0% |
| Q3 2020 | $234,000 | – | 8,254 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |